Global Market Reach Lunit's AI solutions are currently deployed at over 3,500 sites worldwide, demonstrating its extensive international presence and market acceptance, which presents sales opportunities for expansion into untapped regions and healthcare markets.

Regulatory Validation The recent CE certification for Lunit's software in Europe signifies regulatory approval and readiness to deploy in European healthcare systems, creating a strong foot in the door for sales within European clinics and hospitals.

Strategic Collaborations Partnerships with major industry players like Daiichi Sankyo, CellCarta, Agilent Technologies, and Microsoft reveal a strategic approach to integrating Lunit's AI into broader healthcare and biotech ecosystems, offering multiple avenues to introduce solutions to larger healthcare organizations and labs.

Recent high-profile Engagements Participation in the World Economic Forum and collaborations in mass screenings during significant events like the Hajj season highlight Lunit's active engagement with global health initiatives, positioning it to leverage government and large-scale institutional sales opportunities.

Innovative Technology Stack Utilization of advanced tech like CUDA, AWS, and GraphQL facilitates scalable, cloud-based, and high-performance AI solutions, making Lunit's offerings attractive to hospitals seeking innovative, robust diagnostic tools that can be integrated into existing healthcare IT infrastructures.